Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-01-17 @ 3:40 AM
Study NCT ID:
NCT07082868
Status:
RECRUITING
Last Update Posted:
2025-10-20
First Post:
2025-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2028-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-17
First Submit QC Date:
None
Study First Post Date:
2025-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-17
Last Update Post Date:
2025-10-20
Last Update Post Date Type:
ESTIMATED